Charles Albright, EVP/Chief Scientific Officer at Editas Medicine, Inc. (EDIT), sold 3,000 shares at $32.22 ($97K) on 2020-07-15, disclosed to the SEC on 2020-07-17.
Open-market sale of $97k EDIT by EVP/Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EDIT | SELL | 2020-12-08 | $1.6M | — | Filing → |
| EDIT | SELL | 2020-11-10 | $7K | — | Filing → |
| EDIT | SELL | 2020-10-16 | $94K | — | Filing → |